Amy Lankford

Amy Lankford has a strong background in clinical and regulatory development, with experience in managing and coordinating Phase 1-3 clinical trials. Amy has expertise in preparing regulatory submissions, clinical study protocols, investigator brochures, and other study-related documents. Amy has also demonstrated their ability to interpret data and present findings at national and international congresses. Amy has held positions at Precigen, Intrexon Corporation, University of Virginia Cancer Center, Trovis Pharmaceuticals, LLC, and Adenosine Therapeutics, LLC.

Amy Lankford received their PhD in Pharmacology from East Carolina University, where they studied from 1991 to 1996.